mRNA |
CAL-101 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0007 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0007 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0007 |
mRNA |
CGP-082996 |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
0.0007 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0009 |
mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |
mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.001 |
mRNA |
Vorinostat |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.001 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.2 |
0.002 |